Thrombotic Stroke: Clinical Trials

7 trials for Thrombotic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 2 completed, 1 terminated, 1 unknown. 7 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Not yet recruiting 3, Completed 2, Terminated 1, Unknown 1
Phase 22Completed 1, Not yet recruiting 1

Follow Thrombotic Stroke: new trials by email Literature Review of Thrombotic Stroke trials Research Report on Thrombotic Stroke

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
Isosorbide Mononitrate, Butylphthalide, Isosorbide Mononitrate Placebo - Stroke, Lacunar, Stroke, Acute Ischemic
Phase 3Not yet recruitingBeijing Tiantan Hospital31562025-12-012025-11-26
CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN
carbogen with or without phenyleprhine, phenylephrine - Acute Ischemic Stroke
Phase 3Not yet recruitingYonsei University402025-02-012025-01-20
MLC1501 Study Assessing Efficacy in STROke Recovery
MLC1501, Placebo - Stroke, Stroke, Ischemic
Phase 2 / Phase 3Not yet recruitingMoleac Pte Ltd.5402025-01-012023-03-16
Cerebroprotective Effect of Melatonin in Stroke
Melatonin 10 MG, Placebo - Stroke, Acute Ischemic, Strokes Thrombotic
Phase 3UnknownCoordinación de Investigación en Salud, Mexico1002024-03-012024-03-05
Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)
carbogen, phenylephrine - Acute Ischemic Stroke
Phase 3TerminatedYonsei University32021-04-052025-01-14
LACunar Intervention (LACI-2) Trial-2
Isosorbide Mononitrate XL (ISMN), Cilostazol, ISMN XL and Cilostazol - Cerebral Small Vessel Diseases, Stroke, Lacunar
Phase 2 / Phase 3CompletedUniversity of Edinburgh3632018-01-082024-11-12
Secondary Prevention of Small Subcortical Strokes Trial
aspirin, clopidogrel, Target of Blood Pressure - Cerebrovascular Accident, Hypertension
Phase 3CompletedUniversity of British Columbia30202003-02-012013-04-04

Narrower conditions

Ischemic Stroke (5)  ·  Stroke, Lacunar (5)  ·  Cerebral Small Vessel Diseases (2)  ·  Stroke (2)  ·  Alzheimer Disease (1)  ·  Dementia (1)  ·  Embolic Stroke (1)  ·  Hypertension (1)  ·  Myocardial Infarction (1)

Broader conditions

Brain Diseases (7)  ·  Cardiovascular Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cerebrovascular Disorders (7)  ·  Nervous System Diseases (7)  ·  Vascular Diseases (7)  ·  Infarction (6)  ·  Ischemia (6)  ·  Necrosis (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Brain Infarction (5)  ·  Stroke (5)  ·  Cerebral Small Vessel Diseases (3)

Interventions

Phenylephrine (2)  ·  carbogen (2)  ·  3-n-butylphthalide (1)  ·  Aspirin (1)  ·  Cilostazol (1)  ·  Clopidogrel (1)  ·  Melatonin (1)  ·  isosorbide-5-mononitrate (1)

Sponsors

Yonsei University (2)  ·  Beijing Tiantan Hospital (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Moleac Pte Ltd. (1)  ·  University of British Columbia (1)  ·  University of Edinburgh (1)

Countries

Mexico (2)  ·  South Korea (2)  ·  Canada (1)  ·  Chile (1)  ·  Ecuador (1)  ·  Peru (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Christopher Chen, BMBCh, MRCP, FAMS, FRCPE (1)  ·  Hyo Suk Nam, MD, PhD (1)  ·  Joanna M Wardlaw, MB ChB (1)  ·  Oscar Benavente, M.D. (1)  ·  Robert Hart, M.D. (1)  ·  Yilong Wang (1)

Results publications

PMID 20446946, PMID 21371282, PMID 21899409, PMID 22499292, PMID 22750086, PMID 22826359, PMID 22931315, PMID 23034910, PMID 23726159, PMID 23736109, PMID 24177006, PMID 24523037, PMID 24661819, PMID 24862645, PMID 25034716, PMID 25158772, PMID 25190442, PMID 25452300, PMID 25453457, PMID 26019129, PMID 26553236, PMID 26762524, PMID 26888535, PMID 26956031, PMID 28351962, PMID 30686103, PMID 31423869, PMID 32371759, PMID 32905623, PMID 33481011, PMID 35114798, PMID 35224730, PMID 35833913, PMID 36398903, PMID 36876480, PMID 37222252, PMID 38214239

NIH funding

2016 (1)